Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers

Published:2023-12-12 Issue: Volume: Page:1-7
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Chen Ying-Rong¹,Yu Xiang¹,Xu Li-Min²,Mei Jue¹,Tian Meng-Li¹,Xu Min¹,Jin Qiu-Yue¹,Ye Li-Bing³,Yang Shui-Xin¹

Affiliation:

1. Clinical Trial Center, Huzhou Central Hospital, Huzhou, Zhejiang, People’s Republic of China

2. Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Huzhou, Zhejiang, People’s Republic of China

3. Department of pharmacy, Huzhou Central Hospital, Huzhou, Zhejiang, People’s Republic of China

Funder

Furen Pharmaceutical Company Limited, Henan, China

Public Welfare Application Research Project of Huzhou Technology Plan

Youth Talent Program of Huzhou Central Hospital

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2023.2294039

Reference20 articles.

1. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

2. Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

3. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro

4. Safety of gefitinib in non-small cell lung cancer treatment

5. Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non–Small-Cell Lung Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile;Pharmaceuticals;2024-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3